Company Overview of CGI Pharmaceuticals, Inc.
As of July 8, 2010, CGI Pharmaceuticals, Inc. was acquired by Gilead Sciences Inc. CGI Pharmaceuticals, Inc. is a development-stage company focusing on discovery and development of small molecule therapeutics for multiple oncology and immunology-based indications. The company provides drug discovery and development programs, including Btk, a B-cell kinase for a range of AAID and oncology indications; and Syk, a regulator of mast cell, monocyte/macrophage, and B-cell functions. The company was formerly known as Cellular Genomics, Inc. and changed its name to CGI Pharmaceuticals, Inc. in September, 2005. The company was founded in 1998 and is headquartered in Branford, Connecticut.
36 East Industrial Road
Branford, CT 06405
Founded in 1998
Key Executives for CGI Pharmaceuticals, Inc.
CGI Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact CGI Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.